{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:51:09Z","timestamp":1777521069447,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ijantimicag.2011.10.015","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T18:30:20Z","timestamp":1326133820000},"page":"255-258","source":"Crossref","is-referenced-by-count":39,"title":["Comparative Activity of Carbapenem Testing (COMPACT) study in Germany"],"prefix":"10.1016","volume":"39","author":[{"given":"Giuseppe","family":"Valenza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Decker-Burgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Laeuffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinier","family":"Mutters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2011.10.015_bib0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/cc6820","article-title":"Gram-negative antibiotic resistance: there is a price to pay","volume":"12","author":"Slama","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diagmicrobio.2008.11.004","article-title":"MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates","volume":"63","author":"Turner","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0015","unstructured":"Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA; PEG-Resistenzstudie Study Group. PEG-Resistenzstudie 2004. Rheinbach, Germany: Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e.V.; 2004. http:\/\/www.p-e-g.org\/ag_resistenz\/main.htm [accessed 3 January 2011]."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0020","unstructured":"Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA; PEG-Resistenzstudie Study Group. PEG-Resistenzstudie 2007. Rheinbach, Germany: Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e.V.; 2007. http:\/\/www.p-e-g.org\/ag_resistenz\/main.htm [accessed 3 January 2011]."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.9.1.23","article-title":"Carbapenems: a potent class of antibiotics","volume":"9","author":"Nicolau","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0030","unstructured":"European Medicines Agency. Doribax. Annex I. Summary of product characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000891\/WC500037148.pdf [accessed 3 January 2011]."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0035","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0040","unstructured":"Ortho-McNeil. Doribax [prescribing information]. Raritan, NJ: Ortho-McNeil; 2009."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0045","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.0. EUCAST; 2009. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Disk_test_documents\/EUCAST_breakpoints_v1.0_20091221.pdf [accessed 3 January 2011]."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0050","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.2. http:\/\/www.eucast.org\/ [accessed 3 January 2011]."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0055","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0060","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (June 2010 update). Document M100-S20-U. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/mdr.2010.0114","article-title":"Characterization of extended-spectrum \u03b2-lactamases and qnr plasmid-mediated quinolone resistance in German isolates of Enterobacter species","volume":"17","author":"M\u00fcller","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2011.10.015_bib0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijantimicag.2010.08.002","article-title":"In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study","volume":"36","author":"Christiansen","year":"2010","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791100481X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791100481X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T06:57:47Z","timestamp":1543301867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791100481X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S092485791100481X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.10.015","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}